![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel | Paper
Anzahl der Publikationen: 71
Zeitschriftenartikel
Haas, Michael; Ormanns, Steffen; Bächmann, Sibylle; Remold, Anna; Krüger, Stephan; Westphalen, Christoph B.; Siveke, Jens T.; Wenzel, Patrick; Schlitter, Anna Melissa; Esposito, Irene; Quietzsch, Detlef; Clemens, Michael R.; Kettner, Erika; Laubender, Rüdiger P.; Jung, Andreas; Kirchner, Thomas; Böck, Stefan und Heinemann, Volker
(2017):
Extended RAS analysis and correlation with overall survival in advanced pancreatic cancer.
In: British Journal of Cancer, Bd. 116, Nr. 11: S. 1462-1469
Siebermair, Johannes; Sinner, Moritz F.; Beckmann, Britt-Maria; Laubender, Rüdiger P.; Martens, Eimo; Sattler, Stefan; Fichtner, Stephanie; Estner, Heidi L.; Kääb, Stefan und Wakili, Reza
(2016):
Early repolarization pattern is the strongest predictor of arrhythmia recurrence in patients with idiopathic ventricular fibrillation: results from a single centre long-term follow-up over 20 years.
In: Europace, Bd. 18, Nr. 5: S. 718-725
Gamba, Sebastian; Camaj, Peter; Heinemann, Volker; Laubender, Rüdiger P.; Wang, Yan; Zhao, Yue; Stintzing, Sebastian; Giessen, Clemens; Boeck, Stefan; Haertl, Christoph; Bruns, Christiane J. und Modest, Dominik P.
(2015):
Effect of KRAS exon 2 mutations on antitumor activity of afatinib and gefitinib.
In: Anti-Cancer Drugs, Bd. 26, Nr. 4: S. 371-378
[PDF, 251kB]
Michl, M.; Thurmaier, J.; Schubert-Fritschle, Gabriele; Wiedemann, Max; Laubender, Rüdiger P.; Nussler, N. C.; Ruppert, R.; Kleeff, J.; Schepp, W.; Reuter, C.; Lohe, F.; Karthaus, M.; Neumann, J.; Kirchner, T.; Engel, Jutta und Heinemann, V.
(2015):
Brain Metastasis in Colorectal Cancer Patients: Survival and Analysis of Prognostic Factors.
In: Clinical Colorectal Cancer, Bd. 14, Nr. 4: S. 281-290
Modest, Dominik P.; Schulz, Christoph; Fischer von Weikersthal, Ludwig; Quietzsch, Detlef; Einem, J. C. von; Schalhorn, Andreas; Vehling-Kaiser, Ursula; Laubender, Rüdiger P.; Giessen, Clemens; Stintzing, Sebastian und Heinemann, Volker
(2014):
Outcome of patients with metastatic colorectal cancer depends on the primary tumor site (midgut vs. hindgut): analysis of the FIRE1-trial (FuFIRI or mIROX as first-line treatment).
In: Anticancer Drugs, Bd. 25, Nr. 2: S. 212-218
[PDF, 442kB]
Boeck, S.; Ormanns, S.; Haas, M.; Bachmann, S.; Laubender, Rüdiger P.; Siveke, J. T.; Jung, A.; Kirchner, T. und Heinemann, V.
(2014):
Translational research in pancreatic cancer: KRAS and beyond.
In: Pancreas, Bd. 43, Nr. 1: S. 150-152
Michl, M.; Haug, A. R.; Jakobs, T. F.; Paprottka, P.; Hoffmann, R. T.; Bartenstein, P.; Boeck, S.; Haas, M.; Laubender, Rüdiger P. und Heinemann, V.
(2014):
Radioembolization with Yttrium-90 Microspheres (SIRT) in Pancreatic Cancer Patients with Liver Metastases: Efficacy, Safety and Prognostic Factors.
In: Oncology, Bd. 86, Nr. 1: S. 24-32
Laubender, Rüdiger P. und Bender, R.
(2014):
A note on calculating asymptotic confidence intervals for the adjusted risk difference and number needed to treat in the Cox regression model.
In: Statistics in Medicine, Bd. 33, Nr. 5: S. 198-810
Tillack, Cornelia; Ehmann, Laura Maximiliane; Friedrich, Matthias; Laubender, Rüdiger P.; Papay, Pavol; Vogelsang, Harald; Stallhofer, Johannes; Beigel, Florian; Bedynek, Andrea; Wetzke, Martin; Maier, Harald; Koburger, Maria; Wagner, Johanna; Glas, Jürgen; Diegelmann, Julia; Koglin, Sarah; Dombrowski, Yvonne; Schauber, Jürgen; Wollenberg, Andreas und Brand, Stephan
(2014):
Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-gamma-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
In: Gut, Bd. 63, Nr. 4: S. 567-577
Thieme, U.; Schelling, Gustav; Hauer, D.; Greif, R.; Dame, T.; Laubender, Rüdiger P.; Bernhard, W.; Thieme, D.; Campolongo, P. und Theiler, L.
(2014):
Quantification of anandamide and 2-arachidonoylglycerol plasma levels to examine potential influences of tetrahydrocannabinol application on the endocannabinoid system in humans.
In: Drug Testing and Analysis, Bd. 6, Nr. 1-2: S. 17-23
Lee, Serene M. L.; Schelcher, Celine; Laubender, Rüdiger P.; Fröse, Natalja; Thasler, Reinhard M. K.; Schiergens, Tobias S.; Mansmann, Ulrich und Thasler, Wolfgang E.
(2014):
An Algorithm that Predicts the Viability and the Yield of Human Hepatocytes Isolated from Remnant Liver Pieces Obtained from Liver Resections.
In: PLOS ONE 9(10), e107567 [PDF, 4MB]
In: PLOS ONE 9(10), e107567 [PDF, 4MB]
Ormanns, Steffen; Siveke, Jens T.; Heinemann, Volker; Haas, Michael; Sipos, Bence; Schlitter, Anna Melissa; Esposito, Irene; Jung, Andreas; Laubender, Rüdiger P.; Kruger, Stephan; Vehling-Kaiser, Ursula; Winkelmann, Cornelia; Fischer von Weikersthal, Ludwig; Clemens, Michael R.; Gauler, Thomas C.; Märten, Angela; Geissler, Michael; Greten, Tim F.; Kirchner, Thomas und Boeck, Stefan
(2014):
pERK, pAKT and p53 as tissue biomarkers in erlotinib-treated patients with advanced pancreatic cancer: a translational subgroup analysis from AIO-PK0104.
In: BMC Cancer
14:624
[PDF, 408kB]
Übleis, Christopher; Hoyer, X.; van Kriekinge, S. D.; Schuessler, F.; Laubender, Rüdiger P.; Becker, A.; Lehner, S.; Todica, A.; Haug, A.; Bartenstein, P.; Cumming, P.; Germano, G. und Hacker, M.
(2013):
Association between left ventricular mechanical dyssynchrony with myocardial perfusion and functional parameters in patients with left bundle branch block.
In: Journal of Nuclear Cardiology, Bd. 20, Nr. 2: S. 253-261
Rochat, M. K.; Laubender, Rüdiger P.; Kuster, D.; Braendli, O.; Moeller, A.; Mansmann, Ulrich; Mutius, Erika von und Wildhaber, J.
(2013):
Spirometry reference equations for central European populations from school age to old age.
In: PLOS ONE 8(1), e52619 [PDF, 346kB]
In: PLOS ONE 8(1), e52619 [PDF, 346kB]
Zeiss, K.; Parhofer, K. G.; Heinemann, V.; Haas, M.; Laubender, Rüdiger P.; Holdenrieder, S.; Schulz, C. und Boeck, S.
(2013):
Glucose and lipid metabolism in patients with advanced pancreatic cancer receiving palliative chemotherapy.
In: Anticancer Research, Bd. 33, Nr. 1: S. 287-292
Canis, M.; Lechner, A.; Mack, B.; Zengel, P.; Laubender, Rüdiger P.; Koehler, U.; Heissmeyer, V. und Gires, O.
(2013):
CD133 induces tumour-initiating properties in HEK293 cells.
In: Tumor Biology, Bd. 34, Nr. 1: S. 437-443
Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J. und Hacker, M.
(2013):
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.
In: International Journal of Cardiovascular Imaging, Bd. 29, Nr. 7: S. 1645-1653
Averbeck, B.; Rucker, F.; Laubender, Rüdiger P. und Carr, R. W.
(2013):
Thermal grill-evoked sensations of heat correlate with cold pain threshold and are enhanced by menthol and cinnamaldehyde.
In: European Journal of Pain, Bd. 17, Nr. 5: S. 724-734
Weissenbacher, Tobias; Laubender, Rüdiger P.; Witkin, Steven S.; Gingelmaier, Andrea; Schiessl, Barbara; Kainer, Franziskus; Friese, Klaus; Jeschke, Udo; Dian, Darius und Karl, Katrin
(2013):
Diagnostic biomarkers of pro-inflammatory immune-mediated preterm birth.
In: Archives of Gynecology and Obstetrics, Bd. 287, Nr. 4: S. 673-685
Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Ormanns, S.; Haas, M.; Modest, D. P.; Kirchner, T. und Heinemann, V.
(2013):
KRAS mutation status is not predictive for objective response to anti-EGFR treatment with erlotinib in patients with advanced pancreatic cancer.
In: Journal of Gastroenterology, Bd. 48, Nr. 4: S. 544-548
Boeck, S.; Jung, A.; Laubender, Rüdiger P.; Neumann, J.; Egg, R.; Goritschan, C.; Vehling-Kaiser, U.; Winkelmann, C.; Fischer von Weikersthal, L.; Clemens, M. R.; Gauler, T. C.; Marten, A.; Klein, S.; Kojouharoff, G.; Barner, M.; Geissler, M.; Greten, T. F.; Mansmann, Ulrich; Kirchner, T. und Heinemann, V.
(2013):
EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104.
In: British Journal of Cancer BJC, Bd. 108, Nr. 2: S. 469-476
Greif, M.; Ziegler, F. von; Wakili, R.; Tittus, J.; Becker, C.; Helbig, S.; Laubender, Rüdiger P.; Schwarz, W.; D’Anastasi, M.; Schenzle, J.; Leber, A. W. und Becker, A.
(2013):
Increased pericardial adipose tissue is correlated with atrial fibrillation and left atrial dilatation.
In: Clinical Research in Cardiology, Bd. 102, Nr. 8: S. 555-562
Giessen, C.; Fischer von Weikersthal, L.; Laubender, Rüdiger P.; Stintzing, S.; Modest, D. P.; Schalhorn, A.; Schulz, C. und Heinemann, V.
(2013):
Evaluation of prognostic factors in liver-limited metastatic colorectal cancer: a preplanned analysis of the FIRE-1 trial.
In: British Journal of Cancer BJC, Bd. 109, Nr. 6: S. 1428-1436
Giessen, C.; Graeven, U.; Laubender, Rüdiger P.; Modest, D. P.; Schulz, C.; Porschen, R.; Schmiegel, W.; Reinacher-Schick, A.; Hegewisch-Becker, S.; Stintzing, S. und Heinemann, V.
(2013):
Prognostic factors for 60-day mortality in first-line treatment of metastatic colorectal cancer (mCRC): individual patient analysis of four randomised, controlled trials by the AIO colorectal cancer study group.
In: Annals of Oncology, Bd. 24, Nr. 12: S. 3051-3055
Giessen, C.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Stintzing, S.; Modest, D. P.; Mansmann, Ulrich und Heinemann, V.
(2013):
Progression-Free Survival as a Surrogate Endpoint for Median Overall Survival in mCRC: Literature-Based Analysis from 50 Randomized First-Line Trials.
In: Clinical Cancer Research, Bd. 19, Nr. 1: S. 225-235
Giessen, C.; Laubender, Rüdiger P.; Fischer von Weikersthal, L.; Schalhorn, A.; Modest, D. P.; Stintzing, S.; Haas, M.; Mansmann, Ulrich und Heinemann, V.
(2013):
Early tumor shrinkage in metastatic colorectal cancer: Retrospective analysis from an irinotecan-based randomized first-line trial.
In: Cancer Science, Bd. 104, Nr. 6: S. 718-724
Haas, M.; Heinemann, V.; Kullmann, F.; Laubender, Rüdiger P.; Klose, C.; Bruns, C. J.; Holdenrieder, S.; Modest, D. P.; Schulz, C. und Boeck, S.
(2013):
Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
In: Journal of Cancer Research and Clinical Oncology, Bd. 139, Nr. 4: S. 681-689
Heinemann, V.; Ebert, M. P.; Laubender, Rüdiger P.; Bevan, P.; Mala, C. und Boeck, S.
(2013):
Phase II randomised proof-of-concept study of the urokinase inhibitor upamostat (WX-671) in combination with gemcitabine compared with gemcitabine alone in patients with non-resectable, locally advanced pancreatic cancer.
In: British Journal of Cancer BJC, Bd. 108, Nr. 4: S. 766-770
Piotrowski, Katja; Becker, Melanie; Zugwurst, Julia; Biller-Friedmann, Ingeborg; Spoettl, Gerald; Greif, Martin; Leber, Alexander W.; Becker, Alexander; Laubender, Rüdiger P.; Lebherz, Corinna; Göke, Burkhard; Marx, Nikolaus; Parhofer, Klaus G. und Lehrke, Michael
(2013):
Circulating concentrations of GLP-1 are associated with coronary atherosclerosis in humans.
In: Cardiovascular Diabetology
12:117
[PDF, 178kB]
Lieb, M.; Palm, U.; Chiang, S.; Laubender, Rüdiger P.; Nothdurfter, C.; Sarubin, N.; Mokhtari-Nejad, R.; Koller, G. und Soyka, M.
(2013):
Pharmacological challenge with naloxone and cue exposure in alcohol dependence: results of a randomized, double-blind placebo-controlled trial.
In: World Journal of Biological Psychiatry, Bd. 14, Nr. 7: S. 539-546
Mansmann, Ulrich und Laubender, Rüdiger P.
(2013):
Methodologic diligence is needed to define and validate tumor-size response metrics to predict overall survival in first-line metastatic colorectal cancer.
In: Journal of Clinical Oncology, Bd. 31, Nr. 34: S. 4373-4374
Modest, D. P.; Camaj, P.; Heinemann, V.; Schwarz, B.; Jung, A.; Laubender, Rüdiger P.; Gamba, S.; Haertl, C.; Stintzing, S.; Primo, S. und Bruns, C. J.
(2013):
KRAS allel-specific activity of sunitinib in an isogenic disease model of colorectal cancer.
In: Journal of Cancer Research and Clinical Oncology, Bd. 139, Nr. 6: S. 953-961
Modest, D. P.; Laubender, Rüdiger P.; Stintzing, S.; Giessen, C.; Schulz, C.; Haas, M.; Mansmann, Ulrich und Heinemann, V.
(2013):
Early tumor shrinkage in patients with metastatic colorectal cancer receiving first-line treatment with cetuximab combined with either CAPIRI or CAPOX: An analysis of the German AIO KRK 0104 trial.
In: Acta Oncologica, Bd. 52, Nr. 5: S. 956-962
Muehlmann, M.; Koerte, I. K.; Laubender, Rüdiger P.; Steffinger, D.; Lehner, M.; Peraud, A.; Heinen, Florian; Kiefer, M.; Reiser, M. und Ertl-Wagner, Birgit
(2013):
Magnetic Resonance-Based Estimation of Intracranial Pressure Correlates With Ventriculoperitoneal Shunt Valve Opening Pressure Setting in Children With Hydrocephalus.
In: Investigative Radiology, Bd. 48, Nr. 7: S. 543-547
Pomschar, A.; Koerte, I.; Lee, S.; Laubender, Rüdiger P.; Straube, A.; Heinen, Florian; Ertl-Wagner, Birgit und Alperin, N.
(2013):
Correction: MRI Evidence for Altered Venous Drainage and Intracranial Compliance in Mild Traumatic Brain Injury.
In: PLOS ONE 8(12) [PDF, 1MB]
In: PLOS ONE 8(12) [PDF, 1MB]
Pomschar, A.; Koerte, I.; Lee, S.; Laubender, Rüdiger P.; Straube, A.; Heinen, Florian; Ertl-Wagner, Birgit und Alperin, N.
(2013):
MRI evidence for altered venous drainage and intracranial compliance in mild traumatic brain injury.
In: PLOS ONE 8(2), e55447 [PDF, 1MB]
In: PLOS ONE 8(2), e55447 [PDF, 1MB]
Ertl-Wagner, Birgit; Koerte, Inga; Kümpfel, Tania; Blaschek, Astrid; Laubender, Rüdiger P.; Schick, Max; Steffinger, Denise; Kaufmann, David; Heinen, Florian; Reiser, Maximilian; Alperin, Noam und Hohlfeld, Reinhard
(2012):
Non-specific alterations of craniocervical venous drainage in multiple sclerosis revealed by cardiac-gated phase-contrast MRI.
In: Multiple Sclerosis, Bd. 18, Nr. 7: S. 1000-1007
Maier, T.; Braun-Falco, M.; Laubender, Rüdiger P.; Ruzicka, T. und Berking, C.
(2012):
Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology.
In: British Journal of Dermatology, Bd. 168, Nr. 1: S. 120-128
Grunke, M.; Witt, M. N.; Ronneberger, M.; Schnez, A.; Laubender, Rüdiger P.; Engelbrecht, M.; Kavanaugh, A. und Schulze-Koops, H.
(2012):
Use of the 28-Joint Count Yields Significantly Higher Concordance Between Different Examiners Than the 66/68-Joint Count.
In: Journal of Rheumatology, Bd. 39, Nr. 7: S. 1334-1340
Freydanck, M. K.; Laubender, Rüdiger P.; Rack, B.; Schuhmacher, L.; Jeschke, Udo und Scholz, C.
(2012):
Two-marker Combinations for Preoperative Discrimination of Benign and Malignant Ovarian Masses.
In: Anticancer Research, Bd. 32, Nr. 5: S. 2003-2008
Lehner, S.; Todica, A.; Brunner, S.; Übleis, Christopher; Wang, H.; Wängler, C.; Herbach, N.; Herrler, T.; Böning, G.; Laubender, Rüdiger P.; Cumming, P.; Schirrmacher, R.; Franz, W. und Hacker, M.
(2012):
Temporal changes in phosphatidylserine expression and glucose metabolism after myocardial infarction: an in vivo imaging study in mice.
In: Molecular Imaging, Bd. 11, Nr. 6: S. 461-470
Hofheinz, R. D.; Heinemann, V.; Fischer von Weikersthal, L.; Laubender, Rüdiger P.; Gencer, D.; Burkholder, I.; Hochhaus, A. und Stintzing, S.
(2012):
Capecitabine-associated hand-foot-skin reaction is an independent clinical predictor of improved survival in patients with colorectal cancer.
In: British Journal of Cancer BJC, Bd. 107, Nr. 10: S. 1678-1683
Modest, D. P.; Reinacher-Schick, A.; Stintzing, S.; Giessen, C.; Tannapfel, A.; Laubender, Rüdiger P.; Brodowicz, T.; Knittelfelder, R.; Vrbanec, D.; Schmiegel, W.; Heinemann, V. und Zielinski, C. C.
(2012):
Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis.
In: Anticancer Drugs, Bd. 23, Nr. 6: S. 666-673
Connell, L.; Koerte, I. K.; Laubender, Rüdiger P.; Morhard, D.; Linn, J.; Becker, H. C.; Reiser, M.; Brueckmann, H. und Ertl-Wagner, Birgit
(2012):
Hyperdense basilar artery sign-a reliable sign of basilar artery occlusion.
In: Neuroradiology, Bd. 54, Nr. 4: S. 321-327
Schäfer, C.; Seeliger, H.; Bader, D. C.; Assmann, G.; Buchner, D.; Guo, Y.; Ziesch, A.; Palagyi, A.; Ochs, S.; Laubender, Rüdiger P.; Jung, A.; de Toni, E. N.; Kirchner, T.; Göke, Burkhard; Bruns, C. und Gallmeier, E.
(2012):
Heat shock protein 27 as a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma.
In: Journal of Cellular and Molecular Medicine, Bd. 16, Nr. 8: S. 1776-1791
Modest, D. P.; Jung, A.; Moosmann, N.; Laubender, Rüdiger P.; Giessen, C.; Schulz, C.; Haas, M.; Neumann, J.; Boeck, S.; Kirchner, T.; Heinemann, V. und Stintzing, S.
(2012):
The influence of KRAS- and BRAF-mutations on the efficacy of cetuximab-based 1st-line therapy of metastatic colorectal cancer: An analysis of the AIO KRK-0104 -trial.
In: International Journal of Cancer, Bd. 131, Nr. 4: S. 980-986
Haas, M.; Laubender, Rüdiger P.; Klose, C.; Schulz, C.; Mansmann, Ulrich; Boeck, S. und Heinemann, V.
(2012):
External Validation of 2 Prognostic Indices for Patients With Advanced Pancreatic Cancer Treated With First-line Therapy.
In: Pancreas, Bd. 41, Nr. 5: S. 738-744
Übleis, Christopher; Hellweger, S.; Laubender, Rüdiger P.; Becker, A.; Sohn, H. Y.; Lehner, S.; Haug, A.; Bartenstein, P.; Cumming, P.; van Kriekinge, S. D.; Slomka, P. J. und Hacker, M.
(2012):
Left ventricular dyssynchrony assessed by gated SPECT phase analysis is an independent predictor of death in patients with advanced coronary artery disease and reduced left ventricular function not undergoing cardiac resynchronization therapy.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 39, Nr. 10: S. 1561-1569
Maier, T.; Laubender, Rüdiger P.; Sturm, R. A.; Klingenstein, A.; Korting, H. C.; Ruzicka, T. und Berking, C.
(2012):
Osteopontin expression in plasma of melanoma patients and in melanocytic tumours.
In: Journal of the European Academy of Dermatology and Venereology, Bd. 26, Nr. 9: S. 1084-1091
Beigel, Florian; Löhr, Beate; Laubender, Rüdiger P.; Tillack, Cornelia; Schnitzler, Fabian; Breiteneicher, Simone; Weidinger, Maria; Göke, Burkhard; Seiderer, Julia; Ochsenkühn, Thomas und Brand, Stephan
(2012):
Iron Status and Analysis of Efficacy and Safety of Ferric Carboxymaltose Treatment in Patients with Inflammatory Bowel Disease.
In: Digestion, Nr. 1: S. 47-54
[PDF, 464kB]
Weissenbacher, Tobias; Laubender, Rüdiger P.; Witkin, Steven S.; Gingelmaier, Andrea; Schiessl, Barbara; Kainer, Franziskus; Friese, Klaus; Jeschke, Udo; Dian, Darius und Karl, Katrin
(2012):
Influence of maternal age, gestational age and fetal gender on expression of immune mediators in amniotic fluid.
In: BMC Research Notes, Bd. 5, Nr. 1: S. 375
Stallhofer, J.; Denk, G. U.; Glas, J.; Laubender, Rüdiger P.; Göke, Burkhard; Rust, C.; Brand, S. und Pusl, T.
(2011):
Analysis of IL2/IL21 Gene Variants in Cholestatic Liver Diseases Reveals an Association with Primary Sclerosing Cholangitis.
In: Digestion, Bd. 84, Nr. 1: S. 29-35
Giessen, C.; Stintzing, S.; Laubender, Rüdiger P.; Ankerst, Donna Pauler; Schulz, C.; Moosmann, N.; Modest, D. P.; Schalhorn, A.; Fischer von Weikersthal, L. und Heinemann, V.
(2011):
Analysis for Prognostic Factors of 60-day Mortality: Evaluation of an Irinotecan-Based Phase III Trial Performed in the First-Line Treatment of Metastatic Colorectal Cancer.
In: Clinical Colorectal Cancer, Bd. 10, Nr. 4: S. 317-324
Koerte, Inga; Pelavin, Paula; Kirmess, Berit; Fuchs, Teresa; Berweck, Steffen; Laubender, Rüdiger P.; Borggraefe, Ingo; Schroeder, Sebastian; Danek, Adrian; Rummeny, Claudia; Reiser, Maximilian; Kubicki, Marek; Shenton, Martha E.; Ertl-Wagner, Birgit und Heinen, Florian
(2011):
Anisotropy of transcallosal motor fibres indicates functional impairment in children with periventricular leukomalacia.
In: Developmental medicine and child neurology, Bd. 53, Nr. 2: S. 179-186
Koerte, I. K.; Schankin, C. J.; Immler, S.; Lee, S.; Laubender, Rüdiger P.; Grosse, C.; Eftimov, L.; Milde-Busch, A.; Reiser, M.; Straube, A.; Heinen, Florian; Alperin, N. und Ertl-Wagner, Birgit
(2011):
Altered Cerebrovenous Drainage in Patients With Migraine as Assessed by Phase-Contrast Magnetic Resonance Imaging.
In: Investigative Radiology, Bd. 46, Nr. 7: S. 434-440
Zitzmann, K.; de Toni, E.; Ruden, J. von; Brand, S.; Göke, Burkhard; Laubender, Rüdiger P. und Auernhammer, C. J.
(2011):
The novel Raf inhibitor Raf265 decreases Bcl-2 levels and confers TRAIL-sensitivity to neuroendocrine tumour cells.
In: Endocrine-Related Cancer, Bd. 18, Nr. 2: S. 277-285
Modest, D. P.; Stintzing, S.; Laubender, Rüdiger P.; Neumann, J.; Jung, A.; Giessen, C.; Haas, M.; Aubele, P.; Schulz, C.; Boeck, S.; Stemmler, H. J.; Kirchner, T. und Heinemann, V.
(2011):
Clinical characterization of patients with metastatic colorectal cancer depending on the KRAS status.
In: Anticancer Drugs, Bd. 22, Nr. 9: S. 913-918
Jürgens, Matthias; Brand, S.; Laubender, Rüdiger P.; Seiderer, Julia; Glas, Jürgen; Wetzke, M.; Wagner, J.; Pfennig, S.; Tillack, C.; Beigel, Florian; Weidinger, M.; Schnitzler, Fabian; Kreis, M. E.; Göke, Burkhard; Lohse, P.; Herrmann, K. und Ochsenkühn, Thomas
(2010):
The presence of fistulas and NOD2 homozygosity strongly predict intestinal stenosis in Crohn’s disease independent of the IL23R genotype.
In: Journal of Gastroenterology, Bd. 45, Nr. 7: S. 721-731
Bleiziffer, Sabine; Ali, Ayyaz; Hettich, Ina M.; Akdere, Deniz; Laubender, Rüdiger P.; Ruzicka, Daniel; Boehm, Johannes; Lange, Ruediger und Eichinger, Walter
(2010):
Impact of the indexed effective orifice area on mid-term cardiac-related mortality after aortic valve replacement.
In: Heart, Bd. 96, Nr. 11: S. 865-871
[PDF, 388kB]
Haas, M.; Laubender, Rüdiger P.; Stieber, P.; Holdenrieder, S.; Bruns, C. J.; Wilkowski, R.; Mansmann, Ulrich; Heinemann, V. und Boeck, S.
(2010):
Prognostic relevance of CA 19-9, CEA, CRP, and LDH kinetics in patients treated with palliative second-line therapy for advanced pancreatic cancer.
In: Tumor Biology, Bd. 31, Nr. 4: S. 351-357
Glas, Jürgen; Seiderer, Julia; Tillack, Cornelia; Pfennig, Simone; Beigel, Florian; Jürgens, Matthias; Olszak, Torsten; Laubender, Rüdiger P.; Weidinger, Maria; Müller-Myhsok, Bertram; Göke, Burkhard; Ochsenkühn, Thomas; Lohse, Peter; Diegelmann, Julia; Czamara, Darina und Brand, Stephan
(2010):
The NOD2 single nucleotide polymorphisms rs2066843 and rs2076756 are novel and common Crohn's disease susceptibility gene variants.
In: PLOS ONE 5(12), e14466 [PDF, 125kB]
In: PLOS ONE 5(12), e14466 [PDF, 125kB]
Boeck, S.; Haas, M.; Laubender, Rüdiger P.; Kullmann, F.; Klose, C.; Bruns, C. J.; Wilkowski, R.; Stieber, P.; Holdenrieder, S.; Buchner, Hannes; Mansmann, Ulrich und Heinemann, V.
(2010):
Application of a time-varying covariate model to the analysis of CA 19-9 as serum biomarker in patients with advanced pancreatic cancer.
In: Clinical Cancer Research, Bd. 16, Nr. 3: S. 986-994
Horster, S.; Laubender, Rüdiger P.; Lehmeyer, L.; Ankerst, Donna Pauler; Eberle, J.; Reinert, R.; Imohl, M.; van der Linden, M.; Schweiger, B. und Bogner, J. R.
(2010):
Influence of antiretroviral therapy on immunogenicity of simultaneous vaccinations against influenza, pneumococcal disease and hepatitis A and B in human immunodeficiency virus positive individuals.
In: Journal of Infection, Bd. 61, Nr. 6: S. 484-491
Koerte, I.; Eftimov, L.; Laubender, Rüdiger P.; Esslinger, O.; Schroeder, A. S.; Ertl-Wagner, Birgit; Wahllaender-Danek, U.; Heinen, Florian und Danek, Adrian
(2010):
Mirror movements in healthy humans across the lifespan: effects of development and ageing.
In: Developmental Medicine & Child Neurology, Bd. 52, Nr. 12: S. 1106-1112
Laubender, Rüdiger P. und Bender, R.
(2010):
Estimating adjusted risk difference (RD) and number needed to treat (NNT) measures in the Cox regression model.
In: Statistics in Medicine, Bd. 29, Nr. 7-8: S. 851-859
Jürgens, Matthias; Laubender, Rüdiger P.; Hartl, F.; Weidinger, M.; Seiderer, Julia; Wagner, J.; Wetzke, M.; Beigel, Florian; Pfennig, S.; Stallhofer, J.; Schnitzler, Fabian; Tillack, Cornelia; Lohse, Peter; Göke, Burkhard; Glas, Jürgen; Ochsenkühn, Thomas und Brand, Stephan
(2010):
Disease Activity, ANCA, and IL23R Genotype Status Determine Early Response to Infliximab in Patients With Ulcerative Colitis.
In: American Journal of Gastroenterology, Bd. 105, Nr. 8: S. 1811-1819
Lehrke, M.; Becker, A.; Greif, M.; Stark, R.; Laubender, Rüdiger P.; Ziegler, F. von; Lebherz, C.; Tittus, J.; Reiser, M.; Becker, C.; Göke, Burkhard; Leber, A.; Parhofer, K. G. und Broedl, U. C.
(2009):
Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis.
In: European Journal of Endocrinology, Bd. 161, Nr. 2: S. 339-344
Koerte, I.; Heinen, Florian; Fuchs, T.; Laubender, Rüdiger P.; Pomschar, A.; Stahl, R.; Berweck, S.; Winkler, P.; Hufschmidt, A.; Reiser, M. F. und Ertl-Wagner, Birgit
(2009):
Anisotropy of callosal motor fibers in combination with transcranial magnetic stimulation in the course of motor development.
In: Investigative Radiology, Bd. 44, Nr. 5: S. 279-284
Lehrke, Michael; Greif, Martin; Broedl, Uli C.; Lebherz, Corinna; Laubender, Rüdiger P.; Becker, Alexander; Ziegler, Franz von; Tittus, Janine; Reiser, Maximilian; Becker, Christoph; Göke, Burkhard; Steinbeck, Gerhard; Leber, Alexander W. und Parhofer, Klaus G.
(2009):
MMP-1 serum levels predict coronary atherosclerosis in humans.
In: Cardiovascular Diabetology
8:50
[PDF, 308kB]
Sing, A.; Schmoldt, S.; Laubender, Rüdiger P.; Heesemann, J.; Sing, D. und Wildner, M.
(2009):
Seasonal variation of Pneumocystis jirovecii infection: analysis of underlying climatic factors.
In: Clinical Microbiology and Infection, Bd. 15, Nr. 10: S. 957-960
Paper
Laubender, Rüdiger P. und Mansmann, Ulrich
(24. Dezember 2014):
Estimating individual treatment effects from
responses and a predictive biomarker in a
parallel group RCT.
Department of Statistics: Technical Reports, Nr. 176
[PDF, 2MB]